ASX - By Stock
|
AD8 |
Re:
$23 Valuation
|
|
Delbz
|
16 |
7.6K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
16
|
7.6K
|
6
|
|
ASX - By Stock
|
COV |
Re:
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
|
|
Delbz
|
55 |
15K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
55
|
15K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Resignation of Chief Financial Officer
|
|
Delbz
|
72 |
22K |
0 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
72
|
22K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
137
|
63K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Resignation of Chief Financial Officer
|
|
Delbz
|
72 |
22K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
72
|
22K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
137
|
63K
|
2
|
|
ASX - By Stock
|
ADT |
Re:
$5 party
|
|
Delbz
|
22 |
7.5K |
2 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
22
|
7.5K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity to present at ASCO and SNMMI 2023 Annual Meetings
|
|
Delbz
|
10 |
6.1K |
38 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
10
|
6.1K
|
38
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Change of Director's Interest Notice - Rob Thomas
|
|
Delbz
|
8 |
3.2K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
8
|
3.2K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
137
|
63K
|
2
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
2 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
137
|
63K
|
2
|
|
ASX - By Stock
|
ADT |
Re:
$5 party
|
|
Delbz
|
22 |
7.5K |
2 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
22
|
7.5K
|
2
|
|
IPOs
|
|
Re:
VGW
|
|
Delbz
|
914 |
1.0M |
0 |
17/05/24 |
17/05/24 |
IPOs
|
914
|
1.0M
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
5 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
137
|
63K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Delbz
|
209 |
86K |
9 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
209
|
86K
|
9
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
0 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
137
|
63K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Delbz
|
73 |
23K |
3 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
73
|
23K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
Delbz
|
90 |
37K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
90
|
37K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Delbz
|
137 |
63K |
2 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
137
|
63K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. budget pushes for action on screening for Veterans
|
|
Delbz
|
25 |
12K |
10 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
25
|
12K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: S&P DJI Announces March 2024 Quarterly Rebalance
|
|
Delbz
|
1 |
854 |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1
|
854
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Imbio secures research agreement with US Dept of Vet Affairs
|
|
Delbz
|
26 |
7.3K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
26
|
7.3K
|
5
|
|
ASX - By Stock
|
DUR |
Re:
Ann: Results Presentation 1HFY24
|
|
Delbz
|
84 |
41K |
3 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
84
|
41K
|
3
|
|
ASX - By Stock
|
DUR |
Re:
Ann: Results Presentation 1HFY24
|
|
Delbz
|
84 |
41K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
84
|
41K
|
1
|
|
ASX - By Stock
|
DUR |
Re:
Ann: Results Presentation 1HFY24
|
|
Delbz
|
84 |
41K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
84
|
41K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Delbz
|
2.5K |
1.1M |
11 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
2.5K
|
1.1M
|
11
|
|
IPOs
|
|
Re:
VGW
|
|
Delbz
|
914 |
1.0M |
0 |
17/06/23 |
17/06/23 |
IPOs
|
914
|
1.0M
|
0
|
|
ASX - By Stock
|
KRM |
Re:
Kingrose Mining - Banter and General Discussion
|
|
Delbz
|
1.3K |
290K |
10 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
1.3K
|
290K
|
10
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Share Purchase Plan Opens - Letter and Offer Document
|
|
Delbz
|
83 |
46K |
3 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
83
|
46K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Delbz
|
2.5K |
1.1M |
1 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
AD8 |
GAP in the $7
|
|
Delbz
|
0 |
492 |
1 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
0
|
492
|
1
|
|
IPOs
|
|
Re:
VGW
|
|
Delbz
|
914 |
1.0M |
1 |
05/04/23 |
05/04/23 |
IPOs
|
914
|
1.0M
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CUV Appendix 4D Half Year Report
|
|
Delbz
|
42 |
17K |
1 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
42
|
17K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: AGM - Chair & CEO Presentations
|
|
Delbz
|
27 |
11K |
0 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
27
|
11K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: AGM - Chair & CEO Presentations
|
|
Delbz
|
27 |
11K |
1 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
27
|
11K
|
1
|
|
ASX - By Stock
|
TLC |
Re:
TLC LONGS
|
|
Delbz
|
71 |
64K |
1 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
71
|
64K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Supply chain challenges navigated to deliver strong revenue
|
|
Delbz
|
63 |
33K |
1 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
63
|
33K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Supply chain challenges navigated to deliver strong revenue
|
|
Delbz
|
63 |
33K |
0 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
63
|
33K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
Delbz
|
27 |
11K |
1 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
27
|
11K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
Delbz
|
36 |
12K |
4 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
36
|
12K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
Delbz
|
36 |
12K |
2 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
36
|
12K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
Delbz
|
36 |
12K |
4 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
36
|
12K
|
4
|
|
ASX - By Stock
|
VML Mining |
Re:
VML General Comments - Chat
|
|
Delbz
|
8.4K |
3.6M |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
8.4K
|
3.6M
|
1
|
|
ASX - By Stock
|
WC8 |
Re:
Ann: Investor Presentation November 2021
|
|
Delbz
|
5 |
2.9K |
0 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
5
|
2.9K
|
0
|
|
ASX - By Stock
|
AMS |
Re:
Ann: Ceasing to be a substantial holder from WAM, WAA, WMI
|
|
Delbz
|
16 |
4.2K |
0 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
16
|
4.2K
|
0
|
|
ASX - By Stock
|
AMS |
Re:
What’s happening to ams SP?
|
|
Delbz
|
15 |
5.0K |
0 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
15
|
5.0K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Q1 Trading Update
|
|
Delbz
|
26 |
15K |
3 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
26
|
15K
|
3
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: FY21 Annual Report
|
|
Delbz
|
5 |
3.4K |
0 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
5
|
3.4K
|
0
|
|
ASX - By Stock
|
DVP |
Re:
VXR TA
|
|
Delbz
|
256 |
100K |
2 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
256
|
100K
|
2
|
|
ASX - By Stock
|
NST |
Re:
Mis-priced Stock
|
|
Delbz
|
732 |
305K |
0 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
732
|
305K
|
0
|
|